AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Ketorolac Tromethamine in South Africa

7 products registered with SAHPRA — 3 active

Brand / ProductReg. No.HolderStatusExpires
OFLAECT 15 INJECTION54/2.7/0286Hetero Drugs South Africa (Pty) Ltdunknown8 Aug 2028
OFLAECT 60 INJECTION54/2.7/0288Hetero Drugs South Africa (Pty) Ltdunknown8 Aug 2028
OFLAECT 30 INJECTION54/2.7/0287Hetero Drugs South Africa (Pty) Ltdunknown8 Aug 2028
BEDORAL 30A40/2.7/0147Ranbaxy Pharmaceutical (Pty) Ltdsuspended1 Jul 2026
SABAX KETOROLAC 6043/2.7/0179Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900
KELOPT45/15.4/1033Gen-Eye (Pty) Ltdactive1 Jan 1900
SABAX KETOROLAC 3043/2.7/0178Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900

Ketorolac Tromethamine — SAHPRA Registration Details

SAHPRA (South Africa) has 7 registered products containing Ketorolac Tromethamine, of which 3 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Ketorolac Tromethamine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.